Complex valve disease: Pre-surgical functional capacity evaluation using peak oxygen consumption

Journal of Heart Valve Disease

Volumn 18, Issue 5, 2009, Pages 554-561

  Bissessor, Naylin ^a,b   Stewart, Ralph ^b   Wee, Yong Shen ^a   Zeng, Irene ^b   Jayasinghe, Rohan ^a   Howes, Laurence ^a   Kolbe, John ^b   Kerr, Andrew ^b   Lowe, Boris ^b   Ellyett, Kevin ^b   White, Harvey ^b  

^a GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^b Green Lane Clinical and Research Centre ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; EXERCISE TEST; FEMALE; HUMAN; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PROGNOSIS; SPIROMETRY; VALVULAR HEART DISEASE;

ADULT; AGED; BODY COMPOSITION; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; FEMALE; HEART VALVE DISEASES; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PROGNOSIS; SPIROMETRY;

EID: 77449124952     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2006;48:1-148
2. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease:The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268
3. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-3295
4. Wasserman K, Hansen JE, Sue DY. Principles of exercise testing and interpretation. 3rd edition. Lea & Febiger, Philadelphia, 1996
5. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Jr., Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-786
6. Ruppel G. Manual of pulmonary function testing. 6th edition. Mosby-Year Book Inc., St. Louis, Missouri, 1994
7. Anderson B. Echocardiography:The Normal Examination of Echocardiographic Measurements, 2nd edition. Blackwell, Brisbane, 2003
8. Will PM, Walter JD. Exercise testing:Improving performance with a ramped Bruce protocol. Am Heart J 1999;138:1033-1037
9. Wyse DG, Waldo AL, DiMarco JP, et al. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833
10. Jackson AS, Pollock ML. Practical assessment of body composition. Physician Sports Medicine 1985;13:76-90
11. Lehmann G, Kolling K. Reproducibility of cardiopulmonary exercise parameters in patients with valvular heart disease. Chest 1996;110:685-692
12. Singh SN, Tang XC, Singh BN, et al. SAFE-T Investigators. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation:A Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 2006;48:721-730
13. 2. Eur Heart J 2000;21:154-161
14. Choi EY, Shim J, Kim SA, et al. Value of echo-Doppler derived pulmonary vascular resistance, net-atrioventricular compliance and tricuspid annular velocity in determining exercise capacity in patients with mitral stenosis. Circulation 2007;71:1721-1727
15. Sutton TM, Stewart RAH, Gerber IL, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003;41:2280-2287
16. Gerber IL, Stewart RA, French JK, et al. Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. Am J Cardiol 2003;92:755-758